Are We Over-Treating With Checkpoint Inhibitors?

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0570-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

624. Immunovirotherapy Combined With Immune Checkpoint Inhibitors for Treating Glioblastoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Are We Studying and Treating Schizophrenia Correctly?

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2011English

To Contribute to Health, We Need to Understand Who We Are Treating

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2015English

Rare Heart Risk Found With Checkpoint Inhibitors

Cancer
Cancer ResearchOncology
2017English

Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2020English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

Treating ER+ Breast Cancer With CDK4/6 Inhibitors

Cancer Discovery
Oncology
2017English

Effects of Tumor Treating Fields (TTFields) on Glioblastoma Cells Are Augmented by Mitotic Checkpoint Inhibition

Cell Death Discovery
Cancer ResearchMolecular NeuroscienceImmunologyCell BiologyCellular
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy